Christopher Goebel
Cleveland Clinic(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Histone Deacetylase Inhibitors Research, Multiple Sclerosis Research Studies, Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research
Most-Cited Works
- → Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1(2018)53 cited
- → Effects of Ibudilast on MRI Measures in the Phase 2 SPRINT-MS Study(2020)47 cited
- → Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype(2021)14 cited
- → Donepezil for Alzheimer's Disease — The donald study — a multicenter 24 weeks clinical trial in Germany(2000)3 cited
- → A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results(2017)1 cited
- → Donepezil in very elderly Alzheimer patients: Improvements in cognition and quality of life. Results of the 2nd German post marketing surveillance study(2002)1 cited
- [Cycle disorders, polydipsia, decline of vision. Is it the fault of the hypophysis?].(2001)
- → A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML)(2016)
- Characteristics, Mutation Profiles and Outcomes of Patients with Acute Myeloid Leukemia and a History of Autoimmune Disease(2017)